Dataset ID: 21

Back to List

Dataset Details

Study Design
Study Design Background
The development of advanced delivery systems, such as nanoparticles, may help overcome the blood–brain barrier (BBB) and increase brain accessibility. These systems can be exploited to improve the drugs delivery to the brain parenchyma. In addition, radiolabeled nanoparticles can be monitored in the body using positron emission tomography (PET) imaging, providing real-time insights into their pharmacokinetics and biodistribution.
Study Description
In the present work, functionalized liposomes are labeled with the radionuclide fluorine-18, exploiting a “surface radiolabeling” approach for in vivo PET imaging.
Study Type
Preclinical
Study Subtype
In vitro, in vivo, ex vivo
Publication
Paper Linked
Yes
Paper Title
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging
Paper Authors
Marco Iannone, Marcelo Kravicz, Paolo Rainone, Antonia I. Antoniou, Stefano Stucchi, Silvia Valtorta, Arianna Amenta, Elia Anna Turolla, Sara Pellegrino, Daniele Passarella, Elisa Vino, Sergio Todde, Francesca Re, Pierfausto Seneci and Rosa Maria Moresco.
Affiliation
"1. Tecnomed Foundation, University of Milano-Bicocca, Monza, Italy 2. School of Medicine and Surgery,♪University of Milano-Bicocca, Monza, Italy 3. Institute of Bioimaging and Biological Complex Systems (IBSBC), National Research Council (CNR), Segrate, Italy 4. Nuclear Medicine Department, San Raffaele Scientific Institute IRCCS, Milan, Italy 5. Department of Chemistry, University of Milan, Milan, Italy, 6. National Biodiversity Future Center (NBFC), Palermo, Italy 7. GBM-BI-TRACE (Glio Blasto Ma-BIcocca-TRAnslational-CEnter), University of Milano-Bicocca, Monza, Italy 8. Department of Pharmaceutical Sciences, University of Milan, Milan, Italy"
Paper Journal
Frontiers in Pharmacology
Paper Year
2025
Paper DOI
Doi.org 10.3389 fphar.2025.1566257
Open Access
Yes
Study Component
Multi Modality Images
No
Imaging Modality
PET CT
Radiation
Yes
Imaging Coverage
Whole body
Imaging Target
Tumor, brain
Dataset Information
Institution
IBSBC-CNR
PI
Francesca Re
Co PI
Rosa Maria Moresco
Country Of Institution
Italy
Imaging Facility
Laboratory of preclinical molecular imaging
Euro Bio Imaging Node
Multi-Modal Molecular Imaging Italian node (MMMI)
Country Of Imaging Facility
Italy
Funding
Yes
Funding Agency
"Fondazione Regionale per la Ricerca Biomedica, Regione Lombardia, Project: NEVERMIND—New frontiers of engineered nanovectors to improve treatment efficacy and safety in neurological disorders (Project No. CP2_16 2018 to FR)"
Dataset Access
Limited
DUO Data Use Permission
DUO-0000042
DUO Data Use Modifier
DUO-0000046
DUO Investigation
DUO-0000040
Contact Person
In Vivo Experimental Parameters
Number Of Groups
3
Types Of Groups
[18F]C-Lip, [18F]D-Lip, [18F]E-Lip
Overall Sample Size
9
Disease Model
Cancer
Organ Or Tissue
Brain
Sample Size For Each Group
3
Randomization
Yes, tumor growth was assessed by MRI and 18F-FLT PET performed 10 days post cells inoculation, and randomly assigned to expermental groups
Blinding
No
Statistical Methods
ANOVA Bonferroni’s multiple comparison test
Species
Mice
Strain
Nude fox1
Immune Status
Immunodeficient
Sex
Female
Age
7-8 weeks
Age At Start Experiment
8 weeks
Weight
25 g
Source Of Animals
Envigo RMS SRL
Registry Number Of Animal Authorization
N. 1174 2020-PR
Experimental Procedures
Pharmacological Procedures Intervention And Control
No
Blood Sampling
No
Surgical Procedures Including Sham Surgery
Yes
Description Of The Surgical Procedure
Female nude mice, under general anesthesia, were intracranially injected with 500.000 Gli36ΔEGFR cells
Reference To Protocol
Doi.org 10.3389 fonc.2021.664149
Analgesic Name
Isoflurane
Anesthesia For Imaging
Yes
Anesthesia Type
Gas
Duration
20
Anesthesia Drugs
Isoflurane
Anesthesia Dose
2%
Monitoring Regime
Respiratoy, cardiac rate
Euthanasia
Yes
Method
Cervical dislocation
Histology
No
Imaging
Yes
Frequency Of Imaging
10, 60, 120, and 180 min after radilabelled liposome injection
Timing Of Imaging
2 weeks post inoculation
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule
Yes
Contrast Agent Chemical Drug
18[F]-liposome-APOE
Contrast Agent Dose
About 4 MBq
Injection Volume
About 50ul
Route Of Administration
Intravenus
Cell Lines
Yes
Cell Line
Gli36ΔEGFR
Provenance
Molecular Neurooncology Laboratory, MGH, Boston, MA
Image Acquisition
Instrument Vendor
Molecubes
Instrument Type
Β-cube, X-cube
Instrument Specifics
PET- FOV of 72x130 mm; CT- FOV of 64x40 mm
Image Acquisition Parameters
CT scan (exam duration- 4 min, X-Ray beam duration- 90 s, k Vp- 40, current- 400 A, rotation time- 60 s, and angular views- 960), PET scanner for a 20 min static acquisition
Correction
PET- isotope decay and random coincidences correction; CT- ring artifact correction
Raw Data
Yes
QA/QC
Yes
Image Data
Image Type
Processed images (reconstructed PET and CT data)
Image Scale
SUV for PET, HU for CT
Format Compression
DICOM
Dimensions
2D 3D
Overall Number Of Images
36
Field Of View
Max FOV for PET and CT
Dimension Extents
PET CT- 192x192x384
Size Description
PET CT- 76.8 x 76.8 x 154 mm
PI xel Voxel Size Description
PET CT- 400 µm isometric
Image Processing Methods
CT-based normalization
Image Reconstruction Algorithm
PET- OSEM (30 iterations); CT- ISRA (iterative).
Quality Control
Yes
Analyzed Data
Data Used For Analysis
SUV
Updated Year
2025